China Says No technology transfer: The Reliance–and India’s Battery manufacturing at Risk

 

In January 2026, Bloomberg reported that Xiamen Hithium Energy Storage Technology Co. withdrew from technology-sharing discussions with Reliance Industries, citing Beijing’s tightening export controls on battery technology. The implication was direct: India’s largest private company may have been blocked from accessing crucial know-how—placing its gigafactory ambitions in uncertainty.

Both sides responded quickly. Reliance said it was “strongly and categorically” maintaining its battery manufacturing plans and that its 2026 timeline remained unchanged. Hithium, for its part, stated it had made no media comments about any partnership talks.

What was not denied is just as significant. Reliance did not dispute that discussions with Hithium occurred—or that they stalled. Hithium did not reject the possibility of technology-sharing exploration, nor the likelihood that Chinese export controls could limit what happens next. Together, these careful statements suggest a story that is less like a clean break and more like a negotiation constrained by policy.

 

The Real Warning: Dependency Can Be Weaponised

Even if no formal “no” was issued, the episode highlights a structural vulnerability India can no longer ignore.

Reliance—reported to be seeking a license for battery cell technology—was described as negotiating with a Chinese startup founded in 2019. That startup reportedly generated far smaller revenues, yet held valuable chemistry and cell-technology expertise. The gap between the firms is stark: Reliance is dozens of times larger than its counterpart. If such a relationship is plausible, it points to a deeper issue: India’s industrial capability in certain critical layers of the battery value chain still has exposed seams.

And that leads to the uncomfortable question beneath the headlines:
what happens when China does say no—explicitly and decisively?

 

The “Humiliation” Playbook China Learned From Denial

This is not a hypothetical problem. Technology denial has repeatedly shaped great-power competition, and China’s own modern trajectory offers a recurring pattern: embargoes and restrictions may delay progress, but they often accelerate the creation of domestic alternatives.

Many Western export and technology restrictions against China have unintentionally pushed Beijing toward self-reliance. Over time, the denied areas did not remain permanently unreachable. Instead, they became domains where China built competitive—sometimes superior—capabilities.

Consider the broader logic:

• Denial creates scarcity of inputs.
• Scarcity forces mobilised innovation.
• Innovation reduces reliance.
• Reduced reliance strengthens leverage in the next round of competition.

The strategic lesson is not that denial causes instant success. It often involves long gaps, quality compromises, and stretched timelines. But the directional outcome has frequently been transformation: from dependence to capability, from student to competitor.

 

Vulnerability, Illustrated: Batteries Are a Strategic Layer

Now return to batteries and Reliance.

China reportedly tightened restrictions on lithium battery technology transfers in October 2025, requiring export permits for strategic technologies and giving Beijing wide discretion over what can cross borders. A firm like Hithium may want to partner with Indian players—but it operates within a regulatory system that can shut cooperation off regardless of commercial interest.

This is the core problem for India’s battery transition: key parts of the ecosystem still depend on technology controlled by a strategic rival. As a result, India’s gigafactory plans, clean-energy manufacturing ambitions, and EV-related scaling efforts are built on an assumption that China will continue cooperating—and that cooperation, China has no obligation to provide.

An episode like this—real or exaggerated—should concentrate attention on one conclusion:
India’s battery strategy needs resilience against sudden, policy-driven disruption.

 

Reliance’s Accumulation Problem: Patents Without Substitution

Reliance, to its credit, has not been idle.

Since 2021, Reliance New Energy Solar has reportedly invested heavily in battery-related acquisitions across multiple chemistries—aiming to build a domestic knowledge base rather than relying entirely on imports. On paper, the portfolio looks wide: sodium-ion, lithium iron phosphate-related assets, and grid-storage battery research.

However, there is a difference between owning technology rights and delivering industrial scale. Several indicators point to a recurring challenge: acquisitions do not automatically translate into manufacturing maturity, supply-chain control, and repeatable commercial performance.

In other words, the issue may not be a shortage of purchased assets. It may be a shortage of integration—turning acquired IP into an indigenous manufacturing pathway that is strong enough to stand in for denied foreign inputs.

That is why even the possibility of technology denial matters: the assets may not yet function as full substitutes for proven production know-how.

 

The Jio Institute Anomaly: Money Without Battery Depth

A particularly striking question concerns research priorities.

Reliance operates Jio Institute in Navi Mumbai, backed by a large financial commitment and staffed with credible academic leadership. Yet the current programme profile—at least as described in your text—does not include a dedicated battery chemistry, electrochemistry, or energy-storage materials research track.

This creates a mismatch: substantial funds have been directed toward acquiring battery patents from abroad, while the institution designed for deep academic-industry research does not appear to mirror that specific technical mission.

Reliance has demonstrated it can support deep-tech academic partnerships (for example through AI collaborations with top institutions). The unanswered question is whether battery science will receive comparable institutional attention—or whether the company will continue relying on foreign transfers while its own internal research capacity remains underutilised.

 

What Government Has Done Right: Patient Capital and the Missing Bridge

The policy response matters, and your draft highlights an important point: the Modi government has begun building financing infrastructure aimed at precisely the kind of deep-technology development India needs.

The Research, Development and Innovation (RDI) Fund, announced in Budget 2025, is described as a patient capital mechanism, with a long investment horizon meant to reduce the “valley of death” risk that kills promising innovations before scale.

The logic is sound:

• India’s business contribution to R&D is often lower than global norms.
• Corporate spending on in-house research remains comparatively limited.
• Traditional financing frequently cannot tolerate long timelines and early failure.

The fund’s structure—co-investment requirements, incentives for fund managers, and a Technology Readiness focus—could help close the gap between prototypes and commercial execution.

But financing alone is not enough. The final responsibility is whether India’s corporate leaders commit to using this capital aggressively—building the capabilities that reduce dependence rather than merely postponing it.

 

The Missing Middle: Little Giants and India’s MSME Bottleneck

Still, the RDI Fund addresses only one part of a broader ecosystem problem.

India’s battery transition requires not only large champions and conglomerates, but also a thick layer of specialised mid-tier and small firms—suppliers that can iterate materials, manufacturing processes, components, and quality systems.

China’s approach through “Little Giants” is often cited as a model: a tiered recognition and support system that identifies capable firms, pushes them toward specialisation, and integrates them into strategic value chains.

By contrast, India’s MSME landscape—though huge in number—leans heavily toward microenterprises. That is not automatically bad, but it becomes a structural constraint when regulations, credit availability, and compliance costs discourage growth into specialised manufacturing roles.

If India wants batteries built domestically rather than assembled from imported cores, it needs a stronger “middle layer”—the type of specialised firms that can become globally competitive in niche segments.

 

From Vulnerability to Determination: What India Should Do Now

The Reliance–Hithium episode—whatever its exact contours—offers a useful service: it forces a discussion India has long tried to postpone. India’s clean-energy transition depends on technology that could be constrained or withdrawn. That is a strategic risk, not a PR problem.

This is where the historical comparison becomes practical. China’s technological sovereignty was, at least in part, accelerated by denial. India does not need to wait for its own “unforgettable humiliation.” A near-miss—or even a credible threat—should be enough to create urgency.

What should follow is clear:

• strengthen battery R&D depth, not just patent ownership,
• convert corporate investment into manufacturing substitution capability,
• use public patient capital effectively,
• build a specialised manufacturing ecosystem through an approach like “Little Giants,”
• and ensure corporate champions match government ambition with execution.

The question raised by Hithium is not simply “Did China say no?”
It is: “What will India do when China does?”

The answer will determine whether India remains a technology taker—or becomes, finally, a technology maker.